Oracle’s ORCL stretched valuation metrics promote compelling reasons why investors should consider selling the stock in 2025. Oracle currently trades at an elevated EV/EBITDA multiple of 21.89x, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback